(Q34073969)
Statements
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer (English)
Jing Li
Ulka Vaishampayan
Felicity Harper
Pam Pemberton
Elisabeth I. Heath
1 reference
1 reference
1 reference
1 reference